Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that ...
ACS Publications’ commitment to publishing high-quality content continues to attract impactful research that addresses the world’s most important challenges.
scientific journals, and research organizations. Visitors can browse more than 500 individual topics, grouped into 12 main sections (listed under the top navigational menu), covering: the medical ...
The study by Mabey et al., “Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors,” presented a longitudinal clinical ...